tykhr
sign in
free sign up
Marinus Pharmaceuticals Inc
Biotechnology
Healthcare
MRNS
52.55 B shares
NASDAQ US
traded
02 Jan 2024
listed
no
open
10.71
52 week high
10.99
high
10.76
52 week low
3.50
low
10.31
growth
110.53 %
previous Close
10.87
P/E ratio
market cap
345 M
div yield
0
usd
Jun 2023
qoq
revenue
6.08 M
-41.42 %
net incoming
-33.47 M
3.62 %
eps
0.00 %
8.96 %
eps surprise
15.28 %
net profit margin
-550.44 %
-215.00 %
operating incoming
-31.44 M
4.62 %
net change in cash
-19.12 M
79.59 %
cash on hand
128 M
-13.01 %
cost of revenue
386 K
87.38 %
top